Background: Dementia-related mortality increased significantly in the first year of the COVID-19 pandemic in the United States. Explanations for the rise in dementia-related death rates are complex and multi-factorial. Older adults with dementia often have other chronic conditions that result in increased risk of death. Residence in institutional settings, more common among older adults and those with dementia, was associated with COVID-19 mortality, particularly at the beginning of the pandemic. Death rates for both COVID-19 and dementia among the older population have declined since 2020. However, dementia-related death rates remain higher than pre-pandemic levels. This research describes the changing contribution of COVID-19 deaths to overall dementia mortality.
Methods: This analysis uses mortality data from the 2020-2022 National Center for Health Statistics multiple cause-of-death files. Dementia-related deaths are those with International Classification of Diseases, 10th Revision cause-of-death codes F01 (vascular dementia), F03 (unspecified dementia), G30 (Alzheimer disease), or G31 (other degenerative diseases of nervous system) reported anywhere on the death certificate. For adults age 65 and older, we describe the underlying and contributing causes of death associated with dementia mortality by sex, age group, race and Hispanic origin, and place of death.
Results: In 2022, 6.7% of death certificates for adults age 65 and older with dementia recorded anywhere on the death certificate also mentioned COVID-19, a decline from 7.9% in 2021 and 12.0% in 2020 (Figure 1). Declines in the percentage with COVID-19 mentioned were similar for older Black non-Hispanic, White non-Hispanic, and Hispanic decedents. From 2020 to 2022, the percentage of dementia-related deaths with COVID-19 mentioned declined for deaths in nursing homes or hospice facilities (from 13.8% to 6.8%) and increased for deaths at home (from 2.2% to 4.3%). In 2022, for all dementia-related deaths among adults age 65 and older, the leading causes reported as underlying causes of death were dementia (64.6%), heart disease (9.1%), stroke (4.6%), COVID-19 (3.9%), cancer (2.9%), and Parkinson disease (2.4%) (Figure 2).
Conclusions: Dementia-related mortality in the United States increased during the COVID-19 pandemic. To date, dementia-related death rates remain above pre-pandemic levels, but the contribution of COVID-19 to dementia-related deaths has declined.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1002/alz.087689 | DOI Listing |
BMC Rheumatol
January 2025
Montefiore Medical Center, Albert Einstein College of Medicine, Rheumatology, Bronx, NY, USA.
Background: The anti-melanoma differentiation-associated gene 5 (anti-MDA5) antibody-positive dermatomyositis is known for its association with rapidly progressive interstitial lung disease (RP-ILD) and ulcerative skin lesions, often presenting with or without muscle involvement. The aim of this study was to identify distinct clinical and laboratory features that could be used to evaluate disease progression in an ethnically diverse cohort of anti-MDA5 dermatomyositis patients at a U.S.
View Article and Find Full Text PDFPerioper Med (Lond)
January 2025
Department of Anesthesiology, Nanfang Hospital, Southern Medical University, Guangzhou, 510515, Guangdong, China.
Background: In USA, total shoulder arthroplasty (TSA) ranks amongst the top five surgeries that require hospitalization. As a result, the healthcare system in USA could face a considerable financial strain due to the emergence of subsequent pulmonary problems. This study aimed to conduct a thorough examination of the prevalence, influential factors and medical importance of pulmonary complications, with emphasis on pneumonia, respiratory failure and pulmonary embolism (PE) following total shoulder arthroplasty (TSA) procedures in USA.
View Article and Find Full Text PDFInt J Equity Health
January 2025
Department of Pediatric Surgery, University Medical Center Hamburg-Eppendorf, Martinistrasse 52, 20246, Hamburg, Germany.
Background: Predicting burn-related mortality is vital for family counseling, triage, and resource allocation. Several of the burn-specific mortality prediction scores have been developed, including the Abbreviated Burn Severity Index (ABSI) in 1982. However, these scores are not tested for accuracy to support contemporary estimates of the global burden of burn injury.
View Article and Find Full Text PDFImplement Sci Commun
January 2025
Department of Obstetrics and Gynecology, Division of Maternal and Fetal Medicine, University of North Carolina School of Medicine, Chapel Hill, NC, 27599, USA.
Background: Pregnancy related hypertension is a leading cause of preventable maternal morbidity and mortality in the US, with consistently higher rates affecting racial minorities. Many complications are preventable with timely treatment, in alignment with the Alliance for Innovation on Maternal Health's Patient Safety Bundle ("Bundle"). The Bundle has been implemented successfully in inpatient settings, but 30% of preeclampsia-related morbidity occurs in outpatient settings in North Carolina.
View Article and Find Full Text PDFCrit Care
January 2025
Department of Pediatric, West China Second University Hospital, Sichuan University, Chengdu, China.
Background: Patients supported by extracorporeal membrane oxygenation (ECMO) are at a high risk of brain injury, contributing to significant morbidity and mortality. This study aimed to employ machine learning (ML) techniques to predict brain injury in pediatric patients ECMO and identify key variables for future research.
Methods: Data from pediatric patients undergoing ECMO were collected from the Chinese Society of Extracorporeal Life Support (CSECLS) registry database and local hospitals.
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!